Trials / Not Yet Recruiting
Not Yet RecruitingNCT07056439
Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients
A Phase I/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Radiation Dosimetry and Preliminary Diagnostic Efficacy of HRS-1738 in PET/CT Imaging of Patients With Prostate Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety and pharmacokinetics of HRS-1738 injection in adult patients with prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1738 Injection | HRS-1738 injection. |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-07-09
- Last updated
- 2025-07-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07056439. Inclusion in this directory is not an endorsement.